Allscripts to lay off 250

EHR vendor Allscripts plans to lay off 250 employees across the company, according to a report from the Triangle Business Journal.

The staffing cuts impact several company services, including support, solutions management and selling, general and administrative functions, according to the report.

Two years ago, Allscripts President and CEO Paul Black announced plans to hire 350 workers in North Carolina's Research Triangle region over the next four-and-a-half years to expand its research and development work, but anticipated incentives from the state fell through, according to TBJ.

Allscripts' revenue for the first quarter of 2015 totaled $335 million which represents a decline of 2 percent, compared with $340 million in the first quarter of 2014, the company announced on May 7. They also reported bookings totalling $236 million, a 6 percent year-over-year growth.

"While total revenue declined in the quarter, higher margin recurring revenue continues to grow year-over-year and constituted 77 percent of total revenue," Black said.

Read the complete story.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.